Prevention of venous thromboembolism
150 results
1 - 100
Prevention of venous thromboembolism 
Thrombophilia testing for prevention of recurrent venous thromboembolism- Statins for the primary prevention of venous thromboembolism
- Air travel and prevention of venous thromboembolism by medication
- Statins for primary prevention of venous thromboembolism
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Interventions for the primary prevention of venous thromboembolism for hip fracture surgery
- Neuromuscular electrical stimulation for the prevention of venous thromboembolism
- Statins for primary prevention of venous thromboembolism: Cochrane systematic review
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
Enoxaparin better than aspirin for prevention of venous thromboembolism after total hip or knee arthroplasty- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
- Graduated compression stockings in the prevention of postoperative venous thromboembolism
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Combined intermittent pneumatic compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
- Deep vein thrombosis
- Air travel and illness
- Leg oedema
- Patients with initial unprovoked DVT or PE benefit from long-term low-dose aspirin (INSPIRE)
- Cast treatment of lower extremity fractures
- Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
- Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review
- IPC safer and as effective as medical prophylaxis; much better than TEDS
- Rosuvastatin prevents DVT at very high cost
- Evaluation of thrombophilia
- Compression stockings unnecessary for inpatients who undergo elective surgery
- Aspirin is no different than other anticoagulants for VTE prevention after joint replacement surgery
- Benefits/harms of novel oral anticoagulants similar in general population and the elderly
- Sulodexide given long-term may reduce recurrent VTE in patients with initial unprovoked VTE
- Mobile compression device = LMWH for DVT prevention after hip replacement, less bleeding
- Antithrombotic agents in primary health care
- Abelacimab prevents asymptomatic clots better than enoxaparin, but there is no difference in clinical clots or major bleeding
- Low molecular weight heparin in patients with lower-leg immobilization
- Stockings plus anticoagulation more effective to prevent post-op VTE, but anticoagulation increases bleeding
- Aspirin alone may be sufficient protection from postop VTE after total knee arthroplasty